Acute renal failure probably associated with topiramate;Fallo renal agudo probablemente asociado a topiramato

Farmacia Hospitalaria

Volumn 27, Issue 2, 2003, Pages 105-108

  Ferriols Lisart, Rafael ^a   Heras Javierre, A ^a   Sanz Munoz M ^a   Ibanez Benages E ^a   Alos Alminana M ^a  

^a HOSPITAL GENERAL DE CASTELLÓN   (Spain)

Author keywords

Adverse events; Renal failure; Topiramate; Toxicity

Indexed keywords

CREATININE; TOPIRAMATE; UREA;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; ATAXIA; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CREATININE CLEARANCE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG WITHDRAWAL; ECHOGRAPHY; HEMODIALYSIS; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FUNCTION; MALE; OLIGURIA; SOMNOLENCE; TREATMENT PLANNING; VERTIGO;

ADULT; ANTICONVULSANTS; FRUCTOSE; HUMANS; KIDNEY FAILURE, ACUTE; KIDNEY FUNCTION TESTS; MALE; RENAL DIALYSIS;

EID: 0038814185     PISSN: 11306343     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Perucca E. Marketed new antiepileptic drugs: are they better than old-generation agents? Ther Drug Monitor 2002; 24: 74-80.
2. Schwabe SK. Challenges in the clinical development of new antiepileptic drugs. Ther Drug Monitor 2002; 24: 81-4.
3. Privitera MD. Topiramate: a new antiepileptic drug. Ann Pharmacother 1997; 31: 1164-73.
4. Sachdeo RC. Topiramate: clinical profile in epilepsy. Clin Pharmacokinet 1998; 34 (5): 335-46.
5. Reife RA, Lim P, Pledger G. Topiramate: side effect profile in double-blind studies. Epilepsia 1995; 35 (Supl. 3): 34.
6. Biton V, Edwards KR, Montouris GD, Sackellares JC, Harden CL, Kamin M and the Topiramate TPS-TR Study Group. Topiramate titration and tolerability. Ann Pharmacother 2001; 35: 173-9.
7. Littrell KH, Petty RG, Hilligoss NM, Peabody CD, Johnson CG. Weight loss with topiramate. Ann Pharmacother 2001; 35 (9): 1141-2.
8. Hachad H, Ragueneau-Majlessi I, Levy RH. New antiepileptic drugs: review on drug interactions. Ther Drug Monitor 2002; 24: 91-103.
9. Sabers A, Gram L. Newer anticonvulsants. Comparative review of drug interactions and adverse effects. Drugs 2000; 60 (1): 23-33.
10. Anderson GD. A mechanistic approach to antiepileptic drug interactions. Ann Pharmacother 1998; 554-63.
11. Perucca E. Is there a role for therapeutic drug monitoring of new anticonvulsants? Clin Pharmacokinet 2000; 38 (3): 191-204.
12. Naranjo CA. A method for estimating the probability of adverse drug reactions, Clin Pharmacol Ther 1981; 30: 239-45.
13. Karch FE, Lassagna MD. Towards the operational identification of adverse drug reactions. Clin Pharmacol Ther 1997; 21: 247-54.